Health Technology Assessment International Symposium
Global Perspectives on Health Technology Assessment and Policy
—The Paths of the EU, the US, Asia, and Japan—

Date & Time:Thursday, 6th of September, 2012, 10:30-17:40
Venue:Ito Hall, Ito International Research Center (Hongo Campus of The University of Tokyo)
MAP(121KB, PDF)
Organizer:Graduate School of Public Policy (GraSPP), The University of Tokyo
Co-Sponsors:Todai Policy Alternatives Research Institute
The Canon Institute for Global Studies (CIGS)
Language:English
Simultaneous interpretation between English and Japanese will be provided.

Program

10:30-10:40Opening Remarks
Takatoshi Ito, Dean, Graduate School of Public Policy, The University of Tokyo
Toshihiko Fukui, President of the Canon Institute for Global Studies
10:40-11:20Michael Drummond, Professor, The University of York
“Key Principles for the Conduct of HTA for Resource Allocation Decisions”
11:20-12:00François Meyer, Director, International Affirs, French National Authority for Health (HAS)
“Need for Economic Evaluation in French Healthcare—Structure and Role of HAS—”
12:00-12:40Peter Kolominsky-Rabas, Professor & Director,, Center for Health Technology Assessment (HTA) and Public Health, University of Erlangen-Nuremberg, Germany
“Access to Real Innovations in Times of Budget Constraints: the Role of G-BA and IQWiG for HTA in Germany”
12:40-13:30Lunch
13:30-14:30Panel Discussion “Current Situation and Future of HTA in USA & Europe”
Panelist:
M. Drummond
F. Meyer
P. Kolominsky-Rabas
Moderator: Isao Kamae, Project Professor, The University of Tokyo
14:30-14:45Break
14:45-15:10Gordon Liu, Professor, Peking University Guanghua School of Management
“Healthcare Reform and Current Situation of HTA in China”
15:10-15:35Bong-Min Yang, Professor, Seoul National University
“HTA in Korea; Stakeholder Involvement and Challenges Ahead”
15:35-16:00Hong Li, Group Director, GHEOR Emerging Markets, Japan, and Asia, Bristol-Myers Squibb
“Overview of Health Technology Assessment (HTA) from Asia Perspective”
16:00-16:25Donald Yin, Associate Vice President & Head, Global Health Outcome, Merck & Co., Inc.
“Industry Perspective on the Globalization of Health Technology Assessment”
16:25-16:45Yasunori Yoshida, Pharmaceutical Management Director, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare
“Towards the HTA Implementation by MHLW in 2014”
16:45-17:35Panel Discussion “Current Situation and Future of HTA in Asia”
Panelist:
B. Yang
H. Li
D. Yin
Moderator: I. Kamae
17:35-17:40Closing Remarks
Hideaki Shiroyama, Director, Todai Policy Alternatives Research Institute